NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension

por Mulvaney, Eamon P., Reid, Helen M., Bialesova, Lucia, Bouchard, Annie, Salvail, Dany, Kinsella, B. Therese
Publicado 2020